Tandem Diabetes Care Inc (FRA:TD5A)
€ 45.11 0.18 (0.4%) Market Cap: 3.06 Bil Enterprise Value: 3.07 Bil PE Ratio: 0 PB Ratio: 13.10 GF Score: 78/100

Tandem Diabetes Care Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 11:20PM GMT
Release Date Price: €60.3 (+8.06%)
Travis Lee Steed
BofA Merrill Lynch, Research Division - VP

Travis Steed. I work at the -- on the BofA med tech team. And we have the pleasure for having Kim, John and Leigh all 3 here today from Tandem Diabetes.

Kim D. Blickenstaff
Tandem Diabetes Care, Inc. - Executive Chairman of the Board

The 3 musketeers.

Travis Lee Steed
BofA Merrill Lynch, Research Division - VP

Yes, welcome.

Kim D. Blickenstaff
Tandem Diabetes Care, Inc. - Executive Chairman of the Board

We've been talking since 8:00 this morning so we might not have adequate voice.

Questions & Answers

Travis Lee Steed
BofA Merrill Lynch, Research Division - VP

We can get through this. That's perfectly okay. Well I'm sure we can hear you. I guess I wanted to start off first on Q1 since you just reported recently, came in well above I think anyone's expectations. If you look at, go back and look at Q1 what are -- what's the one or two things that really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot